Denali Therapeutics | 4:持股变动声明-高管 Ho Carole
Denali Therapeutics | 4:持股变动声明-高管 Schuth Alexander O.
Denali Therapeutics | 8-K:重大事件
Denali Therapeutics | 4:持股变动声明-董事 Schenkein David P
Denali Therapeutics | 4:持股变动声明-董事 SATO VICKI L
Denali Therapeutics | 4:持股变动声明-高管 Schuth Alexander O.
Denali Therapeutics | SC 13G:超过5%持股股东披露文件-Capital Research Global Investors(5.5%)
Denali Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(7.084%),Abigail P. Johnson(7.084%)
Denali Therapeutics | 144:拟议出售证券
Denali Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(9.6%)
Denali Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Wellington Management Group LLP(7.49%),Wellington Group Holdings LLP(7.49%)等
Denali Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Biogen Inc.(4.97%),Biogen MA Inc.(4.97%)
Denali Therapeutics | 144:拟议出售证券
Denali Therapeutics | 10-Q:2024财年三季报
Denali Therapeutics | 8-K:Denali Therapeutics公布2024年第三季度财务业绩和业务亮点
Denali Therapeutics | 4:持股变动声明-董事 SATO VICKI L
Denali Therapeutics | 4:持股变动声明-高管 Watts Ryan J.
Denali Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(9.6%)
Denali Therapeutics | 144:拟议出售证券
Denali Therapeutics | 8-K:重大事件
暂无数据
暂无数据